These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7691140)

  • 1. Treatment of juvenile rheumatoid arthritis.
    Emery HM
    Curr Opin Rheumatol; 1993 Sep; 5(5):629-33. PubMed ID: 7691140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological management of juvenile rheumatoid arthritis.
    Rose CD; Doughty RA
    Drugs; 1992 Jun; 43(6):849-63. PubMed ID: 1379157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current treatment of juvenile rheumatoid arthritis.
    Ilowite NT
    Pediatrics; 2002 Jan; 109(1):109-15. PubMed ID: 11773549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of synthetic drugs in the biologic era: therapeutic strategies for treating juvenile idiopathic arthritis.
    Hügle B; Horneff G
    Expert Opin Pharmacother; 2016; 17(5):703-14. PubMed ID: 26678914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoregulatory drugs in the treatment of juvenile rheumatoid arthritis (JRA).
    Høyeraal HM
    Scand J Rheumatol Suppl; 1988; 76():305-10. PubMed ID: 3075085
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritis.
    Rose CD; Singsen BH; Eichenfield AH; Goldsmith DP; Athreya BH
    J Pediatr; 1990 Oct; 117(4):653-9. PubMed ID: 2213397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of the upper extremity in juvenile rheumatoid arthritis.
    Glueck D; Gellman H
    J Am Acad Orthop Surg; 2005; 13(4):254-66. PubMed ID: 16112982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-steroidal anti-inflammatory drugs and slow-acting anti-rheumatic drugs in juvenile rheumatoid arthritis.
    Fujikawa S
    Acta Paediatr Jpn; 1993 Oct; 35(5):447-53. PubMed ID: 8256630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
    O'Dell JR; Haire CE; Erikson N; Drymalski W; Palmer W; Eckhoff PJ; Garwood V; Maloley P; Klassen LW; Wees S; Klein H; Moore GF
    N Engl J Med; 1996 May; 334(20):1287-91. PubMed ID: 8609945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of second-line antirheumatic drugs.
    Haagsma CJ; van Riel PL
    Ann Med; 1997 Apr; 29(2):169-73. PubMed ID: 9187235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of methotrexate therapy for juvenile rheumatoid arthritis.
    Lin YT; Tsai MJ; Wang LH; Huang MT; Yang YH; Chiang BL
    J Formos Med Assoc; 2000 Aug; 99(8):623-9. PubMed ID: 10969505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABC of rheumatology. Arthritis in children.
    Southwood TR
    BMJ; 1995 Mar; 310(6981):728-32. PubMed ID: 7711544
    [No Abstract]   [Full Text] [Related]  

  • 14. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
    van Vollenhoven RF; Ernestam S; Geborek P; Petersson IF; Cöster L; Waltbrand E; Zickert A; Theander J; Thörner A; Hellström H; Teleman A; Dackhammar C; Akre F; Forslind K; Ljung L; Oding R; Chatzidionysiou A; Wörnert M; Bratt J
    Lancet; 2009 Aug; 374(9688):459-66. PubMed ID: 19665644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhupus syndrome in children: A multi-center retrospective cohort study and literature review.
    Sener S; Batu ED; Sahin S; Yildirim DG; Ekinci MK; Kisaoglu H; Karali Y; Demir S; Kaya Akca U; Gunalp A; Turkmen S; Kavrul Kayaalp G; Arslanoglu C; Torun R; Basaran O; Pac Kisaarslan A; Sozeri B; Aktay Ayaz N; Bakkaloglu SA; Kilic SS; Kalyoncu M; Bilginer Y; Unsal E; Kasapcopur O; Ozen S
    Lupus; 2024 Mar; 33(3):273-281. PubMed ID: 38226485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deflazacort. A review of its pharmacological properties and therapeutic efficacy.
    Markham A; Bryson HM
    Drugs; 1995 Aug; 50(2):317-33. PubMed ID: 8521761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical management of children with juvenile rheumatoid arthritis.
    Cassidy JT
    Drugs; 1999 Nov; 58(5):831-50. PubMed ID: 10595864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate in juvenile rheumatoid arthritis. Do the benefits outweigh the risks?
    Giannini EH; Cassidy JT
    Drug Saf; 1993 Nov; 9(5):325-39. PubMed ID: 8280401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 1989 Jun; 31(795):61-4. PubMed ID: 2567489
    [No Abstract]   [Full Text] [Related]  

  • 20. Current treatment for chronic arthritis in childhood.
    Cron RQ
    Curr Opin Pediatr; 2002 Dec; 14(6):684-7. PubMed ID: 12436035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.